Remove Licensing Remove Pharmacy Remove Sales
article thumbnail

Centre puts onus on SLAs to take action against e-pharmacies for violation of D&C Act and Rules

AuroBlog - Aurous Healthcare Clinical Trials blog

With the chemists and druggists across the country opposing the sale of drugs through online, the Central government is taking a stand that the sale of medicines should be strictly under the provisions of the existing regulations and the State Licensing Authorities (SLAs) are legally empowered to act against violation of the legal provisions.

Pharmacy 188
article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. . Ganio says that, ideally, once an individual receives a positive Covid-19 result, they should call their pharmacy or communicate through a drive-through facility to minimize the risk of exposure.

Pharmacy 278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules

Drug Channels

We also offer licenses to our secure hosted learning environmentno internal setup required! Sorry, individual licenses are not currently available.) You'll learn how money and medicines move between manufacturers, wholesalers, pharmacies, PBMs, and payersand how each relationship affects costs and outcomes.

article thumbnail

Digital health player UpHealth swells with three-way merger

pharmaphorum

The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients. The largest by far was the $18.5

article thumbnail

Neurocrine Biosciences’ Crenessity Approved as First New Treatment in Decades for Rare Genetic Disorder CAH

XTalks

Neurocrines hit drug generated $613 million in sales during the third quarter and is projected to reach $2.3 In 2018, the company also received approval for Orilissa (elagolix), which it licenses to AbbVie, for the treatment of endometriosis. billion in revenue by 2024.

Genetics 116
article thumbnail

China Opens the Door to Personal Medicine Imports and Third-Party Online Platform Sales

Pharmacy Checkers

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! The law does not relate specifically to “online pharmacies.”

Sales 64
article thumbnail

Roche Invests $5.3B in Zealand’s Petrelintide, an Obesity Drug Candidate

XTalks

Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4 billion $1.4